GlassScriptPhysician profile
Busra Cangut
NPI 1972180263
$1,908.18
in general payments reported to CMS, 2019-2025
10 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2022: $311 · 2023: $1,109 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $1,109 · Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $1,108.80 |
| Food and Beverage | $339.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,108.80 | 2023 | |
| Edwards Lifesciences Corporation | $202.46 | 2025 | Mitris Resilia Mitral Valve |
| W. L. Gore & Associates, INC. | $148.67 | 2021 | |
| Tela Bio, INC. | $129.37 | 2022 | |
| Silk Road Medical, INC. | $117.53 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $64.31 | 2022 | |
| Abbott Laboratories | $39.67 | 2025 | Epic |
| Novartis Pharmaceuticals Corporation | $36.86 | 2025 | |
| Lemaitre Vascular, INC. | $31.88 | 2025 | Restoreflow |
| Abiomed | $28.63 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Busra Cangut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.